UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

Journal of the American College of Cardiology, 2019-08, Vol.74 (5), p.631-641

2019

Volltextzugriff (PDF)

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

European urology, 2019-12, Vol.76 (6), p.790-813

2019

Volltextzugriff (PDF)

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

Vaccine, 2006-08, Vol.24 (33), p.5937-5949

2006

Volltextzugriff (PDF)

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

European heart journal, 2011-11, Vol.32 (22), p.2851-2906

2011

Volltextzugriff (PDF)

Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells

PloS one, 2011, Vol.6 (7), p.e20775-e20775

2011

Volltextzugriff (PDF)

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting

Vaccine, 2015-07, Vol.33 (32), p.4025-4034

2015

Volltextzugriff (PDF)

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: results from a phase II, randomized, multicenter trial

Clinical immunology (Orlando, Fla.), 2016-08, Vol.169, p.16-27

2016

Volltextzugriff (PDF)

Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults

npj vaccines, 2022-10, Vol.7 (1), p.132-132, Article 132

2022

Volltextzugriff (PDF)

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years

Human vaccines, 2011-12, Vol.7 (12), p.1359-1373

2011

Volltextzugriff (PDF)

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: Follow-up through Month 48 in a Phase III randomized study

Human vaccines & immunotherapeutics, 2014-12, Vol.10 (12), p.3455-3465

2014

Volltextzugriff (PDF)

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

The American journal of tropical medicine and hygiene, 2020-07, Vol.103 (1), p.132-141

2020

Volltextzugriff (PDF)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

The Journal of immunology (1950), 2012-05, Vol.188 (10), p.5054-5062

2012

Volltextzugriff (PDF)

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

Human vaccines & immunotherapeutics, 2019-09, Vol.15 (9), p.2090-2105

2019

Volltextzugriff (PDF)

Évaluation de la réorganisation sensorimotrice par imagerie fonctionnelle par résonance magnétique après replantation de la main

Hand surgery and rehabilitation, 2021-12, Vol.40 (6), p.898-898

2021

Volltextzugriff (PDF)

Reprise de l’activité professionnelle après une chirurgie de prothèse trapézo-métacarpienne: Étude rétrospective de 193 patients

Hand surgery and rehabilitation, 2021-12, Vol.40 (6), p.885-885

2021

Volltextzugriff (PDF)

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS

Vaccine, 2006-04, Vol.24 (15), p.2850-2859

2006

Volltextzugriff (PDF)

Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children

The American journal of tropical medicine and hygiene, 2016-06, Vol.94 (6), p.1348-1358

2016

Volltextzugriff (PDF)

Safety and immunogenicity of candidate vaccine M72/AS01Ein adolescents in a TB endemic setting

Vaccine, 2015-07, Vol.33 (32), p.4025

2015

Volltextzugriff (PDF)

Safety and Immunogenicity of an AS03 B -Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

The American journal of tropical medicine and hygiene, 2020-07, Vol.103 (1), p.132

2020

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(29)
Bücher
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(19)
Science & Technology
(18)
Life Sciences & Biomedicine
(15)
Female
(13)
Male
(10)
Adult
(9)
Immunology
(8)
Vaccines
(8)
Middle Aged
(7)
Adolescent
(6)
Antibodies, Viral - Blood
(5)
Cd4-Positive T-Lymphocytes - Immunology
(5)
Plasmodium Falciparum
(5)
Antigens
(4)
Biological And Medical Sciences
(4)
Biotechnology & Applied Microbiology
(4)
Immunization
(4)
Infant
(4)
Lymphocytes
(4)
Malaria
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children

T Cell Responses to the RTS,S/AS01.sub.E and RTS,S/AS02.sub.D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children

Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: results from a phase II, randomized, multicenter trial

Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: Follow-up through Month 48 in a Phase III randomized study

Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

TCT-647 Predictors and Clinical Impact of Myocardial Injury Following Transcatheter Aortic Valve Replacement: Insights from a Large Multicenter Registry

Évaluation de la réorganisation sensorimotrice par imagerie fonctionnelle par résonance magnétique après replantation de la main

Reprise de l’activité professionnelle après une chirurgie de prothèse trapézo-métacarpienne: Étude rétrospective de 193 patients

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS

Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children

Safety and immunogenicity of candidate vaccine M72/AS01Ein adolescents in a TB endemic setting

Safety and Immunogenicity of an AS03 B -Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

Suchergebnisse filtern